134 related articles for article (PubMed ID: 36717446)
1. SkQ1 as a Tool for Controlling Accelerated Senescence Program: Experiments with OXYS Rats.
Kolosova NG; Kozhevnikova OS; Muraleva NA; Rudnitskaya EA; Rumyantseva YV; Stefanova NA; Telegina DV; Tyumentsev MA; Fursova AZ
Biochemistry (Mosc); 2022 Dec; 87(12):1552-1562. PubMed ID: 36717446
[TBL] [Abstract][Full Text] [Related]
2. Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats.
Loshchenova PS; Sinitsyna OI; Fedoseeva LA; Stefanova NA; Kolosova NG
Biochemistry (Mosc); 2015 May; 80(5):596-603. PubMed ID: 26071779
[TBL] [Abstract][Full Text] [Related]
3. Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
Muraleva NA; Zhdankina AA; Fursova AZ; Kolosova NG
Biochemistry (Mosc); 2024 Feb; 89(2):201-211. PubMed ID: 38622090
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats.
Stefanova NA; Fursova AZh; Kolosova NG
J Alzheimers Dis; 2010; 21(2):479-91. PubMed ID: 20555140
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
[TBL] [Abstract][Full Text] [Related]
6. Programmed Aging of Mammals: Proof of Concept and Prospects of Biochemical Approaches for Anti-aging Therapy.
Skulachev MV; Skulachev VP
Biochemistry (Mosc); 2017 Dec; 82(12):1403-1422. PubMed ID: 29486692
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
Kolosova NG; Tyumentsev MA; Muraleva NA; Kiseleva E; Vitovtov AO; Stefanova NA
Curr Alzheimer Res; 2017; 14(12):1283-1292. PubMed ID: 28637402
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.
Rumyantseva YV; Ryabchikova EI; Fursova AZ; Kolosova NG
Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):237-48. PubMed ID: 25267419
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.
Stefanova NA; Ershov NI; Kolosova NG
Oxid Med Cell Longev; 2019; 2019():3984906. PubMed ID: 31396299
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression.
Markovets AM; Fursova AZ; Kolosova NG
PLoS One; 2011; 6(7):e21682. PubMed ID: 21750722
[TBL] [Abstract][Full Text] [Related]
11. The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy.
Perepechaeva ML; Grishanova AY; Rudnitskaya EA; Kolosova NG
J Ophthalmol; 2014; 2014():530943. PubMed ID: 25132985
[TBL] [Abstract][Full Text] [Related]
12. The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats.
Muraleva NA; Kozhevnikova OS; Zhdankina AA; Stefanova NA; Karamysheva TV; Fursova AZ; Kolosova NG
Cell Cycle; 2014; 13(22):3499-505. PubMed ID: 25483086
[TBL] [Abstract][Full Text] [Related]
13. The glutamate/GABA system in the retina of male rats: effects of aging, neurodegeneration, and supplementation with melatonin and antioxidant SkQ1.
Telegina DV; Antonenko AK; Fursova AZ; Kolosova NG
Biogerontology; 2022 Oct; 23(5):571-585. PubMed ID: 35969289
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats.
Obukhova LA; Skulachev VP; Kolosova NG
Aging (Albany NY); 2009 Apr; 1(4):389-401. PubMed ID: 20195490
[TBL] [Abstract][Full Text] [Related]
15. MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.
Muraleva NA; Kolosova NG; Stefanova NA
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34208998
[TBL] [Abstract][Full Text] [Related]
16. SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats.
Muraleva NA; Stefanova NA; Kolosova NG
Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731533
[TBL] [Abstract][Full Text] [Related]
17. [The senescence-accelerated oxys rats--a genetic model of premature aging and age-dependent degenerative diseases].
Kolosova NG; Stefanova NA; Korbolina EE; Fursova AZh; Kozhevnikova OS
Adv Gerontol; 2014; 27(2):336-40. PubMed ID: 25306668
[TBL] [Abstract][Full Text] [Related]
18. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects.
Skulachev VP
Biochemistry (Mosc); 2007 Dec; 72(12):1385-96. PubMed ID: 18205623
[TBL] [Abstract][Full Text] [Related]
19. An attempt to prevent senescence: a mitochondrial approach.
Skulachev VP; Anisimov VN; Antonenko YN; Bakeeva LE; Chernyak BV; Erichev VP; Filenko OF; Kalinina NI; Kapelko VI; Kolosova NG; Kopnin BP; Korshunova GA; Lichinitser MR; Obukhova LA; Pasyukova EG; Pisarenko OI; Roginsky VA; Ruuge EK; Senin II; Severina II; Skulachev MV; Spivak IM; Tashlitsky VN; Tkachuk VA; Vyssokikh MY; Yaguzhinsky LS; Zorov DB
Biochim Biophys Acta; 2009 May; 1787(5):437-61. PubMed ID: 19159610
[TBL] [Abstract][Full Text] [Related]
20. Effects of the mitochondria-targeted antioxidant SkQ1 on sexually motivated behavior in male rats.
Amstislavskaya TG; Maslova LN; Gladkikh DV; Belousova II; Stefanova NA; Kolosova NG
Pharmacol Biochem Behav; 2010 Aug; 96(2):211-6. PubMed ID: 20470816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
